Neurologic Features in Severe SARS-CoV-2 Infection
By J. Helms, S. Kremer, Hamid Merdji, Raphaël Clere-Jehl, M. Schenck, C. Kummerlen, O. Collange, C. Boulay, S. Fafi-Kremer, M. Ohana and 2 more. New England Journal of Medicine, 2020
2,311 citations recorded by the source corpus.
Neurologic Features in SARS-CoV-2 Infection In a consecutive series of 64 patients with Covid-19 and ARDS, 58 of whom underwent neurologic examination, severe agitation and corticospinal signs were...
Subfields: Critical Care and Intensive Care Medicine, Neurology
View Paper: https://www.semanticscholar.org/paper/5abfd38ed01072148f7760a158a5a3482d0dd42d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
Citations in the corpus
- Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. (2020, background): “NIH Stroke Scale score, median (IQR) 16 (6-23)”
- Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic (2020, neutral): “61 The only other systematic assessment of neuro-psychiatric presentations was from a preprint 98 that found altered consciousness to be present in 17 (21”
- COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection (2021, background): “However, magnetic resonance (MRI) did not detect abnormal findings in the olfactory bulb and tract and no sign of nasal obstruction was observed [46].”